Abstract submission SGBCC 2027
The abstract submission to SGBCC 2027 will start in August 2026 and will be possible until December 2026. The submitted works will be reviewed by an international jury of experts which will also select the best abstracts for the coveted SGBCC poster awards. Accepted works will be published after the conference and showcased during the event in the e-poster gallery, where the best submissions will also be featured as oral presentations.
Abstract Guidelines
Language: English
Title: max. 200 characters (incl. spaces)
Length: max. 2500 characters (incl. spaces) incl. max. 3 tables
Structure: Goals, Methods, Results, Conclusions
Abstract Topics
- Adjuvant systemic therapy
- Targeted therapy
- Biology / Pathology / Genetics / Basic Research
- Biomarkers
- Diagnostics / Imaging / Artificial Intelligence
- Epidemiology / Prevention
- Locally advanced disease
- Radiotherapy / IORT
- Neoadjuvant (pre-operative) therapy
- Predictive and prognostic factors
- Surgery / Sentinels / DCIS
- Trials in Progress
- Supportive care
- Health politics / Guidelines
- Psycho-Oncology
- Patient navigation / Advovacy
- Survivorship issues
- Low and Middle Income Countries – Specific Issues
- Other
Publication & Presentation
All accepted scientific contributions will be published in “The Breast” by Elsevier after the conference.
During the conference they will be presented as e-posters as part of the e-poster exhibition. The winners of the poster awards will also be asked to hold a short oral presentation. Details on e-poster formatting and submission will be shared with the abstract notifications in January 2027.
Have a look back at the abstracts submitted for SGBCC 2025 which were published in “The Breast” by Elsevier Publishers!
Important Dates for SGBCC 2027
Mark your calendar to not miss any of our key dates and deadlines for your attendance and abstract submission to SGBCC 2027!
